Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-08 |
mRNA | ATP6AP2 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-08 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
mRNA | KRTAP1-5 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-08 |
mRNA | PSAP | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | PMS1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
mRNA | ANP32A | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
mRNA | CDC40 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | UCK2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |